Company intelligence / Profile preview

Zhongzhu Healthcare

Zhuhai, Guangdong, China

Ownership: Private
Employees: ~1246
Development stage: Other

Overview

Zhongzhu Healthcare commercializes multiple ophthalmology drugs (including acyclovir, sodium cromolyn, hydroxybenzazole hydrochloride, and gatifloxacin eye drops/tablets), tumor therapy devices (e.g., gamma knife), and is developing a class 1.1 chemical drug (Leonurine/SCM-198 for stroke/lipids) and Genistein capsules for osteoporosis. No pipeline programs are listed as in advanced clinical development, as marketed generics and devices form the commercial backbone.

Therapeutic areas: OncologyNeurologyEndocrinologyOphthalmology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Zhongzhu Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhongzhu Healthcare.

Explore the full profile